We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$339B
AUM Growth
+$32.7B
Cap. Flow
+$7.03B
Cap. Flow %
2.08%
Top 10 Hldgs %
18.14%
Holding
3,647
New
148
Increased
2,572
Reduced
501
Closed
58

Sector Composition

Rank Sector Weight
1 Technology 21.96%
2 Financials 12.71%
3 Healthcare 11.98%
4 Consumer Discretionary 10.85%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSLT
3151
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$488K ﹤0.01%
316,569
+18,933
+6% +$31.2K
RAIN
3152
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$485K ﹤0.01%
37,595
+18,698
+99% +$267K
INFI
3153
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$485K ﹤0.01%
215,450
CODX
3154
Co-Diagnostics
CODX
$5.31M
$483K ﹤0.01%
1,801
WNEB icon
3155
Western New England Bancorp
WNEB
$259M
$482K ﹤0.01%
55,016
VIGI icon
3156
Vanguard International Dividend Appreciation ETF
VIGI
$9.08B
$481K ﹤0.01%
5,630
-341
-6% -$30.3K
ATOS icon
3157
Atossa Therapeutics
ATOS
$20.6M
$480K ﹤0.01%
19,962
KNTK icon
3158
Kinetik
KNTK
$3.72B
$479K ﹤0.01%
15,616
DV icon
3159
DoubleVerify
DV
$1.73B
$478K ﹤0.01%
14,345
+7,488
+109% +$250K
VATE icon
3160
INNOVATE Corp
VATE
$111M
$478K ﹤0.01%
12,899
NAGE
3161
Niagen Bioscience
NAGE
$271M
$478K ﹤0.01%
127,636
+4,824
+4% +$26K
XLF icon
3162
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
$476K ﹤0.01%
12,189
-1,326,818
-99% -$52.2M
STR
3163
DELISTED
Sitio Royalties
STR
$475K ﹤0.01%
24,345
SYRE icon
3164
Spyre Therapeutics
SYRE
$8.54B
$473K ﹤0.01%
3,979
URG
3165
Ur-Energy
URG
$485M
$472K ﹤0.01%
386,525
+2,803
+0.7% +$4.59K
BFX
3166
DELISTED
BowFlex Inc.
BFX
$470K ﹤0.01%
76,586
IMUX icon
3167
Immunic
IMUX
$190M
$468K ﹤0.01%
4,889
+345
+8% +$31.1K
CSPR
3168
DELISTED
Casper Sleep Inc.
CSPR
$468K ﹤0.01%
70,042
AGS
3169
DELISTED
PlayAGS
AGS
$467K ﹤0.01%
68,707
FBIO icon
3170
Fortress Biotech
FBIO
$104M
$467K ﹤0.01%
12,434
DAKT icon
3171
Daktronics
DAKT
$955M
$466K ﹤0.01%
92,085
-41
-0% -$216
SYRS
3172
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$466K ﹤0.01%
14,273
-6
-0% -$243
ODC icon
3173
Oil-Dri
ODC
$1.44B
$463K ﹤0.01%
28,292
NATH icon
3174
Nathan's Famous
NATH
$402M
$460K ﹤0.01%
7,861
PKOH icon
3175
Park-Ohio Holdings
PKOH
$575M
$459K ﹤0.01%
21,649

Similar funds

Charles Schwab's Q4 2021 Portfolio in Review

As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
  • Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
  • Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
  • Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
  • Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
  • Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
  • Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.

Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.